Home/March Biosciences/Leah Dimascio, PhD
LD

Leah Dimascio, PhD

Chief Operating Officer

March Biosciences

Roles

Chief Operating OfficeratMarch Biosciences
US Clinical Operation HeadatBioCity Biopharma

March Biosciences Pipeline

DrugIndicationPhase
MB-105CD5+ relapsed or refractory T-cell lymphomas (TCL)Phase 2